Scanderm is a biotech startup studio with dermatology focus since 2015.
In the past year, 800k users from 120 countries used our services, and we got 11 marketing awards (including Effie).
We work with top international Big Pharma companies as GlaxoSmithKline, Bayer, Sanofi, Novartis; retail’s leader in Russia - Magnit Cosmetics (6k stores); and government bodies as Moscow City Hall, Ministry of Industry and Trade, Ministry of Digital development.
Our key technology is personal care recommendations based on skin, nails, and hair AI analysis by a photo made by phone.
The Government of South Korea chose our team among 2,568 companies from 129 countries for the KSGC program.
In the past year, 800k users from 120 countries used our services, and we got 11 marketing awards (including Effie).
We work with top international Big Pharma companies as GlaxoSmithKline, Bayer, Sanofi, Novartis; retail’s leader in Russia - Magnit Cosmetics (6k stores); and government bodies as Moscow City Hall, Ministry of Industry and Trade, Ministry of Digital development.
Our key technology is personal care recommendations based on skin, nails, and hair AI analysis by a photo made by phone.
The Government of South Korea chose our team among 2,568 companies from 129 countries for the KSGC program.
Location: Russia, Moscow
Employees: 11-50
Founded date: 2015
Investors 1
| Date | Name | Website |
| 24.12.2021 | K-Startup ... | k-startupg... |
Mentions in press and media 3
| Date | Title | Description |
| 03.03.2022 | Shinhan Financial Group, Shinhan Square Bridge (S2 Bridge) Incheon Successful completion of overseas startup support program, "Bridge to Korea (B2K)" | Involvement of six global start-up companies related to deep-tech, med-tech, and digital health from Singapore, Greece, Germany, and Russia Four strart-up companies have received domestic and foreign investment, including the dedicated fund... |
| - | Медицина без ограничений: как она изменилась за последние годы и почему ИИ незаменим в здравоохранении | Медицинские технологии развиваются все стремительнее. Органы, напечатанные на 3D-принтере, генная терапия, иммунотерапия при онкологических заболеваниях — все это уже стало реальностью. Рассказываем, какие инновационные технологии делают на... |
| - | Успехи выпускников «Московского акселератора». Выпуск 5 | Мы продолжаем писать об успехах компаний – выпускников нашего проекта. Герои сегодняшнего выпуска: TRANSBAZA, BPIUM, MONTRANS и Scanderm. 0 Обсудить 31 просмотров TRANSBAZA В мае 2022 года выпускник «Московского Акселератора» TRANSBAZA совм... |